
Vorstellung des SFB 1066 auf Youtube
In diesem von der Universitätsmedizin Mainz produziertem Video stellt sich der SFB 1066 vor. Es werden die grundlegenden Ideen der…
multi-functional nanoparticulate drug carriers for the immunotherapy of malignant melanoma. With this goal, chemists, biologists and physicians are working intensively together in three complementary and closely networked areas:
Through the synthesis of new materials and structures, we are creating the basis for the production of a broad range of nanoparticulate drug carriers that allow chemical modification for adaptation to biomedical issues and as a prerequisite for localized action.
of the interplay of newly synthesized nanoparticles with biological media and cells in vitro and in vivo, we are investigating the molecular requirements for cell uptake and biodistribution in order to address the immune system as effectively as possible.
on tumor cells and immune cells in vitro and in various preclinical in vivo models of malignant melanoma, we are testing the effect on tumor growth and the immune response directed against the tumor. We are pursuing the concept of enhancing effective tumor-specific immune responses by combining activation of the innate and adaptive immune system, directed modulation of immune tolerance, and induction of inflammation restricted to the tumor.
In diesem von der Universitätsmedizin Mainz produziertem Video stellt sich der SFB 1066 vor. Es werden die grundlegenden Ideen der…
Inside Cover Barz et al. In dieser Sonderausgabe ist neben wissenschaftlichen Artikeln, die sich mit der Herstellung und Verhalten von…
Bei der ersten gemeinsamen Tagung des Sonderforschungsbereichs 1066 und des Transregios 319 nahmen zahlreiche Doktoranden beider Forschungsbereiche teil. In zwei…
10.-12. Mai An der diesjährigen CIMT Tagung in Mainz nahmen wieder zahlreiche Mitglieder des SFB 1066 teil. Außerdem freuen wir…